http://www.chemocentryx.com
ChemoCentryx, Inc. Company Intro
Positive topline data from pivotal Phase III ADVOCATE trial demonstrates avacopan’s superiority over standard of care in ANCA-associated vasculitis.
Industry
Healthcare
ChemoCentryx, Inc. Headquaters
850 Maude Avenue
Mountain View,94043
United States
ChemoCentryx, Inc. Share price
18 Jan 2021 01:18 GMT
$63.03
-0.36 (-0.57 %)
ChemoCentryx, Inc. Market cap
$4.292 B
WMC RANKING
2021
ChemoCentryx, Inc. # 82
BiotechnologyLatest ChemoCentryx, Inc. News
16 Jan 2021
ChemoCentryx, Inc. (NASDAQ:CCXI) 50.47% Above its 52 ...
In last trading session, ChemoCentryx, Inc. (NASDAQ:CCXI) saw 526,653 shares changing hands with its beta currently measuring 1.39. Company's recent per ...
16 Jan 2021
Global Atypical Hemolytic Uremic Syndrome Drug Market Analysis highlights the impact of Covid-19 (2020-2025) | Top Players like Achillion Pharmaceuticals Inc, Akari Therapeutics Plc, Alexion Pharmaceuticals Inc, Amgen Inc, ChemoCentryx Inc
... of Covid-19 (2020-2025) | Top Players like Achillion Pharmaceuticals Inc, Akari Therapeutics Plc, Alexion Pharmaceuticals Inc, Amgen Inc, ChemoCentryx Inc.
16 Jan 2021
ChemoCentryx, Inc. (NASDAQ:CCXI) 50.47% Above its 52 ...
In last trading session, ChemoCentryx, Inc. (NASDAQ:CCXI) saw 526,653 shares changing hands with its beta currently measuring 1.39. Company's recent per ...
WMC Market Score
WMC Market to Revenue Score
ChemoCentryx, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| ChemoCentryx, Inc. | USD | $70,036 | $111,755 | $-41,008 | $42,920B | 82 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $552,660B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $342,740B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $586,520B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $273,380B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total ChemoCentryx, Inc. Social Followers vs Top 4 Industry Competitors
ChemoCentryx, Inc. Post vs Top 4 Industry Competitors
ChemoCentryx, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
ChemoCentryx, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
ChemoCentryx, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| ChemoCentryx, Inc. | 0.76 | 0.40 | 3.35 | 0 | 0 | 0 | 1.93 |
| Regeneron Pharmaceuticals, Inc. | 100 | 65.98 | 28.72 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.08 | 100 | 60 | 0 | 0 | 90.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.81 | 86 | 0 | 0 | 99.97 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
